Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Emster Kurt Von
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   302,614    

Indirect Shares

   18,297,697      
Direct Value   $5,393,134    

Indirect Value

   $160,482,323      
Total Shares   18,600,311      
Total Value   $165,875,457      


Rigel Pharmaceuticals Inc $211,805 Crispr Therapeutics Ag $4,836,600 Vera Therapeutics, Inc. $0 Amplitude Healthcare Acquisition Corp $344,729 Rigel Pharmaceuticals Inc $211,805 Crispr Therapeutics Ag $4,836,600 Vera Therapeutics, Inc. $0 Amplitude Healthcare Acquisition Corp $344,729
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2003-06-26 173,611 2004-02-19 4,350,516    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2013-03-06 0 2013-03-06 0    Premium*  
            Crispr Therapeutics Ag CRSP Director 2018-06-05 90,000 2018-12-18 1,171,268    Premium*  
            Cymabay Therapeutics, Inc. CBAY 2024-03-22 0 2023-09-29 18,406    Premium*  
            Vaxcyte, Inc. PCVX Director 2020-06-16 0 2020-06-16 4,168,718    Premium*  
            Vera Therapeutics, Inc. VERA Director 2021-05-17 17,828 2021-05-18 2,960,231    Premium*  
            Amplitude Healthcare Acquisition... AMHCU Director 2023-04-13 21,175 2021-09-24 5,628,558    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-10-31 4 AS $9.27 $487,352 I/I (52,573) 1,220,791 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-12-18 4 S $7.43 $397,365 I/I (53,492) 131,036 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-02-13 4 AS $13.51 $744,104 I/I (55,078) 518,461 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2016-10-24 4 B $14.00 $784,000 I/I 56,000 2,601,814 2.1 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2012-04-02 4 A $0.00 $0 D/D 59,423 59,423 0 -
SOMX Somaxon Pharmaceuticals, ... Director   –       •      –    2012-07-02 4 A $0.00 $0 D/D 61,579 121,002 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2018-12-18 4/A S $29.70 $1,869,168 I/I (62,925) 1,171,268 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2018-01-05 4 B $22.75 $1,499,999 I/I 65,934 1,887,202 2.1 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-02-15 4 AS $14.49 $995,637 I/I (68,712) 286,770 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2018-12-18 4 S $29.70 $2,077,101 I/I (69,925) 1,164,268 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-10-03 4 S $7.81 $554,041 I/I (70,940) 1,280,000 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-01-30 4 AS $12.22 $1,042,843 I/I (85,339) 581,685 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2017-08-28 4 AS $19.79 $1,741,738 I/I (88,011) 1,951,359 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-02-01 4 AS $12.15 $1,070,391 I/I (88,098) 481,287 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-12-17 4 S $8.17 $726,223 I/I (88,889) 184,528 0 -
CBAY Cymabay Therapeutics, Inc...   –       •      –    2024-03-22 4 D $0.00 $0 D/D (90,000) 0 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-09-28 4 S $8.15 $736,670 I/I (90,389) 1,509,611 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2018-01-05 4 AS $26.96 $2,489,406 I/I (92,337) 1,821,268 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-09-29 4 S $8.04 $970,709 I/I (120,735) 1,388,876 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-01-19 4 AS $10.25 $1,338,486 I/I (130,584) 844,715 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-01-22 4 AS $10.40 $1,437,831 I/I (138,253) 706,462 0 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-07-19 4 B $6.50 $999,999 I/I 153,846 1,753,846 2.1 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2018-02-14 4 AS $16.69 $2,720,120 I/I (162,979) 355,482 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-02-19 4 S $20.00 $3,447,460 I/I (172,373) 4,350,516 -
CBAY Cymabay Therapeutics, Inc... Director   –       •      –    2017-12-22 4 AS $9.41 $1,629,304 I/I (173,192) 993,231 0 -
  108  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us